Cite
MLA Citation
Mark A Samaan et al.. “Vedolizumab: early experience and medium-term outcomes from two UK tertiary IBD centres.” Frontline gastroenterology, vol. 8, no. 3, 2017, pp. 196–202. http://access.bl.uk/ark:/81055/vdc_100137792752.0x00000c